Toxicity of OEPA Chemotherapy Regimen for Hodgkin Lymphoma in Children, Adolescents and Young Adults

被引：0
|
作者：
Cirt, R. [1 ]
Garnier, N. [2 ]
Virelizier, E. Nicolas [3 ]
Marec-Berard, P. [1 ]
Penel-Page, M. [1 ]
机构：
[1] Leon Berard Canc Ctr, Inst Pediat Hematol & Oncol, Lyon, France
[2] Hosp Civils Lyon, Inst Pediat Hematol & Oncol, Lyon, France
[3] Leon Berard Canc Ctr, Hematol Unit, Lyon, France
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0779
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [41] Hodgkin's Lymphoma in adolescents and adults
    Bredenfeld, H.
    Haverkamp, H.
    Gilman, E.
    Diehl, V.
    Engert, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 63 - 63
  • [42] Risk Adapted Therapy Utilizing Upfront Brentuximab Vedotin (Bv) and Rituximab (R) with Reduced Toxicity Chemotherapy in the Treatment OF Children, Adolescents and Young Adults (CAYA) with Newly Diagnosed Hodgkin Lymphoma (HL)
    Hochberg, Jessica
    Klejmont, Liana
    Harrison, Lauren
    Flower, Allyson
    Shi, Qiuhu
    Basso, Jaclyn
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S3 - S3
  • [43] BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group
    Kelly, Kara M.
    Sposto, Richard
    Hutchinson, Raymond
    Massey, Vickie
    McCarten, Kathleen
    Perkins, Sherrie
    Lones, Mark
    Villaluna, Doojduen
    Weiner, Michael
    BLOOD, 2011, 117 (09) : 2596 - 2603
  • [44] Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
    Crosswell, Howland E.
    LaCasce, Ann S.
    Bartlett, Nancy L.
    Straus, David J.
    Savage, Kerry J.
    Zinzani, Pier Luigi
    Collins, Graham P.
    Fanale, Michelle
    Fenton, Keenan
    Dong, Cassie
    Miao, Harry
    Grigg, Andrew P.
    HAEMATOLOGICA, 2024, 109 (03) : 982 - 987
  • [45] Low cardiac toxicity following immunochemotherapy with reduced anthracycline dosing in children, adolescents and young adults with B-cell Non-Hodgkin lymphoma
    Hochberg, Jessica
    Chu, Yaya
    Shi, Qiuhu
    D'Souza, Marise
    Goldman, Stan
    Barth, Matthew
    Basso, P. N. P. Jaclyn
    Harrison, R. N. Lauren
    Flower, Allyson
    Friedman, Deborah
    Cairo, Mitchell
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 94 - 94
  • [46] The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?
    Flerlage, Jamie E.
    Metzger, Monika L.
    Bhakta, Nickhill
    BLOOD, 2018, 132 (04) : 376 - 384
  • [47] Hodgkin's Lymphoma in Young Adults
    Khabarova, R.
    Kulyova, S.
    Ivanova, S.
    Senchurov, E.
    Mikhailova, E.
    Borokshinova, K.
    Sakhautdinov, G.
    Kartashova, V.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S464 - S465
  • [48] Paraneoplastic syndromes in association with Hodgkin Lymphoma in adolescents and young adults: a review of literature
    Eissa, Shaimaa Samir
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 104 - 104
  • [49] Racial Disparities in Children, Adolescents, and Young Adults with Hodgkin Lymphoma Enrolled in the New York State Medicaid Program
    Kahn, Justine M.
    Zhang, Xiuling
    Kahn, Amy R.
    Castellino, Sharon M.
    Neugut, Alfred I.
    Schymura, Maria J.
    Boscoe, Francis P.
    Keegan, Theresa H. M.
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2022, 11 (04) : 360 - 369
  • [50] Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population-based study
    Kahn, Justine M.
    Maguire, Frances B.
    Li, Qian
    Abrahao, Renata
    Flerlage, Jamie E.
    Alvarez, Elysia
    Keegan, Theresa H. M.
    CANCER, 2021, 127 (24) : 4613 - 4619
12345